What Is CEA?
CEA stands for carcinoembryonic antigen, a protein normally produced in larger amounts before birth. Healthy adults usually have very low levels in their blood.
CEA is known as a tumor marker because its concentration may increase in certain cancers, particularly colorectal cancer, which affects the colon or rectum.
However, CEA is not specific to cancer. An elevated result can have several explanations.
Why Do Doctors Measure CEA?
CEA is particularly useful in people who have already been diagnosed with colorectal cancer.
Doctors may measure it before treatment and then monitor changes during or after treatment.
Falling levels may support evidence that treatment is working. Rising levels may indicate that further investigation is needed.
CEA can also be elevated in some other cancers, including those affecting the lungs, pancreas, stomach, and breast.
However, not every cancer produces measurable amounts of CEA.
What Can Cause Elevated CEA Levels?
Several noncancerous conditions may increase CEA, including:
- Smoking.
- Liver disease.
- Inflammatory bowel conditions, such as Crohn’s disease.
- Pancreatitis, or inflammation of the pancreas.
- Certain respiratory conditions.
Smoking is particularly important because smokers may have higher CEA concentrations even without cancer.
A mildly elevated result therefore needs careful interpretation rather than immediate conclusions.
What Is a Normal CEA Level?
Reference ranges depend on the laboratory and testing method.
Many laboratories use an upper limit of approximately 3 nanograms per millilitre for nonsmokers, while somewhat higher values may be accepted for smokers.
There is no single threshold that reliably distinguishes cancer from noncancerous conditions.
A normal CEA result does not exclude cancer, and an elevated result cannot establish a diagnosis.
Why Are Changes Over Time Important?
In patients with certain diagnosed cancers, repeated CEA measurements may provide more useful information than a single result.
Doctors compare current values with earlier measurements to identify meaningful changes.
However, an increase does not necessarily mean that cancer has returned. Further assessment, including imaging when appropriate, may be needed.
Can CEA Be Part of Proactive Health Assessment?
Proactive healthcare considers personal risk factors, family history, symptoms, and previous medical findings.
When CEA is included in a broader laboratory assessment, the result should be interpreted within this individual clinical context.
However, CEA is not a validated routine screening test for colorectal cancer or other cancers in healthy people.
For colorectal cancer prevention and early detection, established methods such as stool-based screening tests and colonoscopy are considerably more important.
An individual laboratory result should never replace recommended screening or the investigation of persistent symptoms.
